Correction to: A nanoemulsion/micelles mixed nanosystem for the oral administration of hydrophobically modified insulin

Affiliations

• ¹ Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain.
• ² Department of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain.
• ³ Department of Physical Chemistry, Faculty of Chemistry, University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain.
• ⁴ Cellular Neuroanatomy and Molecular Chemistry of Central Nervous System Group, School of Pharmacy, University of Castilla-La Mancha, 02071, Albacete, Spain.
• ⁵ Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha, 02071, Albacete, Spain.
• ⁶ Instituto de Investigação E Inovação Em Saúde (i3S), Instituto Nacional de Engenharia Biomédica (INEB), Universidade Do Porto, Rua Alfredo Allen 208, 4200-135, Porto, Portugal.
• ⁷ Instituto de Investigacão E Formacão Avançada Em Ciências E Tecnologias da Saúde (CESPU), 4585-116, Gandra, Portugal.
• ⁸ Advanced Drug Delivery and Biomaterials, Université Catholique de Louvain, Louvain Drug Research Institute, 1200, Brussels, Belgium.
• ⁹ Neoplasia & Endocrine Differentiation Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida15782, Santiago de Compostela, Spain.
• ¹⁰ ECSIN-European Center for the Sustainable Impact of Nanotechnology, ECAMRICERT SRL, Padova, Italy.
• ¹¹ Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain. mariaj.alonso@usc.es.
• ¹² Department of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain. mariaj.alonso@usc.es.